"The FDA was slow to respond to the claims of the Raelians--probably because they did not take them seriously," says Murray. "The jurisdictional authority the FDA was claiming may be a stretch, and the sanctions may not be very strong." Jaenisch accused would-be cloners of bad science for disregarding the dangers of human cloning in a recent article (R. Jaenisch, I. Wilmut, "Don't Clone Humans!" Science, 291:2552, March 30, 2001). House committee chairman Billy Tauzin, (R-La.) commented that legislation banning human cloning would be aggressively sought. Sean Tipton, ASRM spokesman, hopes that such legislation would specifically restrict "transfer of a cloned embryo for gestation and birth," and not impede other types of research.
News Notes
A single all-embracing effort to characterize the human proteome is an unlikely prospect (D. Steinberg, "Is a Human Proteome Project Next?" The Scientist, 15[7]:1, April 2, 2001). Nevertheless, smaller-scale--though still massive--proteomics projects keep springing up. On April 4, Myriad Genetics Inc. (MGI), Hitachi Ltd., and Oracle Corp. announced a $185 million, three-year collaboration to identify all protein-protein interactions and biochemical pathways in the human body. Myriad Proteomics I
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Meet the Author
Douglas Steinberg
This person does not yet have a bio.View full profile
Published In
Share
